PARP12 and breast cancer: The individual samples were correctly classified with 88% and 85% of confidence, respectively to be placed in the YA-BC or MA-BC group (Fig 1). Correlation analyses between these genes and clinicopathological features indicated that under-expression of PARP12 in YA-BC showed a significant association with positive lymph nodes (p = 0.03) (S2 Table).